Oncology
Nurses offer interventions for global problem By Susan Trossman, RN “City life is millions of people being lonesome together,” the 19th century naturalist and…
Screening and management of hepatitis C
Use education to dispel the myths about the disease and increase screening and treatment. Takeaways: Hepatitis C infection is a significant public health issue…
Improving patient satisfaction with discharge videos
Standardizing patient education with technology establishes a culture of patient safety. Takeaways: Technology—electronic health records, patient portals, telemedicine, and social media—is playing an increasingly…
Getting to know incoming ANA President Ernest Grant
Special September Frontline Preview This summer, Ernest Grant, PhD, RN, FAAN, was elected to serve as president of the American Nurses Association (ANA) effective…
Venous thromboembolism: Very troubling events
Venous Thromboembolism (VTE) is the number-one cause of preventable death in hospitalized patients. (See VTE facts.) A thrombus is a clot that forms in…
Creative wellness: A missing link in boosting well-being
Expressing yourself through the arts can be one of the more enjoyable components of an overall wellness plan. According to the American Public Health…
Adult survivors of childhood cancer struggle financially
What happens to adults who’ve survived cancer during childhood? Recent research from St. Jude Children’s Research Hospital indicates that they may be struggling. The…
FDA approves new treatment for adrenal cancer
On July 30, the U.S. Food and Drug Administration (FDA) approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults…
Lung cancer mortality for women projected to increase more than 40% worldwide by 2030
The global age-standardized lung cancer mortality rate among women is projected to increase by 43% from 2015 to 2030, according to an analysis of…
Recurrent respiratory papillomatosis in children
Treatment for this rare disorder may require repeat surgeries. Takeaways: Recurrent respiratory papillomatosis (RRP) is disease, but it’s progressive and can effect quality of…
FDA approves drugs for breast cancer
On July 18, the U.S. Food and Drug Administration (FDA) approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal…
Introduction to immunotherapy: What nurses need to know about emerging therapies
Understanding these rapidly evolving treatments will help you advocate for patients and manage side effects. By Beth Boseki, MSN, RN, OCN, CCRP; Lauren FInaldi, BSN,…
THE LONELINESS EPIDEMIC
Nurses offer interventions for global problem By Susan Trossman, RN “City life is millions of people being lonesome together,” the 19th century…
Screening and management of hepatitis C
Use education to dispel the myths about the disease and increase screening and treatment. Takeaways: Hepatitis C infection is a significant public…
Improving patient satisfaction with discharge videos
Standardizing patient education with technology establishes a culture of patient safety. Takeaways: Technology—electronic health records, patient portals, telemedicine, and social media—is playing…
Getting to know incoming ANA President Ernest Grant
Special September Frontline Preview This summer, Ernest Grant, PhD, RN, FAAN, was elected to serve as president of the American Nurses Association…
Venous thromboembolism: Very troubling events
Venous Thromboembolism (VTE) is the number-one cause of preventable death in hospitalized patients. (See VTE facts.) A thrombus is a clot that…
Creative wellness: A missing link in boosting well-being
Expressing yourself through the arts can be one of the more enjoyable components of an overall wellness plan. According to the American…
Adult survivors of childhood cancer struggle financially
What happens to adults who’ve survived cancer during childhood? Recent research from St. Jude Children’s Research Hospital indicates that they may be…
FDA approves new treatment for adrenal cancer
On July 30, the U.S. Food and Drug Administration (FDA) approved Azedra (iobenguane I 131) injection for intravenous use for the treatment…
Lung cancer mortality for women projected to increase more than 40% worldwide by 2030
The global age-standardized lung cancer mortality rate among women is projected to increase by 43% from 2015 to 2030, according to an…
Recurrent respiratory papillomatosis in children
Treatment for this rare disorder may require repeat surgeries. Takeaways: Recurrent respiratory papillomatosis (RRP) is disease, but it’s progressive and can effect…
FDA approves drugs for breast cancer
On July 18, the U.S. Food and Drug Administration (FDA) approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment…
Introduction to immunotherapy: What nurses need to know about emerging therapies
Understanding these rapidly evolving treatments will help you advocate for patients and manage side effects. By Beth Boseki, MSN, RN, OCN, CCRP; Lauren…
Poll




NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.












